文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

病毒性肺炎所致急性呼吸窘迫综合征患者选择气管插管有创机械通气的影响因素

[Factors influencing the choice of endotracheal intubation and mechanical ventilation in patients with acute respiratory distress syndrome caused by viral pneumonia].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论病毒性肺炎所致ARDS患者入RICU 24小时内PaO2/FiO2是选择气管插管机械通气的最佳预测指标,截断值151 mmHg时AUC 0.903、敏感度91.1%、特异度95.1%。

该回顾性研究纳入新疆医科大学第一附属医院RICU 2017年11月至2022年3月收治的117例病毒性肺炎所致ARDS患者,其中气管插管机械通气(ETI-MV)组61例、非ETI-MV组56例。多因素Logistic回归显示,入RICU 24小时内肺浸润影分布范围≥3/4肺野、APACHE II评分≥16.5、PaO2/FiO2、CD4+ T淋巴细胞计数及院内细菌感染是ETI-MV的独立影响因素。ROC曲线显示PaO2/FiO2预测价值最大(AUC 0.903),截断值151 mmHg时敏感度91.1%、特异度95.1%。作者认为,对病毒性肺炎所致ARDS患者,PaO2/FiO2仍是选择ETI-MV的经典参考,而肺浸润影分布范围和入RICU 24小时内全身病情严重程度可为决定是否选择ETI-MV提供补充信息,尤其对中度ARDS。

要点

  • 病毒性肺炎所致ARDS患者入RICU 24小时内PaO2/FiO2预测ETI-MV的AUC为0.903,截断值151 mmHg时敏感度91.1%、特异度95.1%。
  • 肺浸润影分布范围≥3/4肺野预测ETI-MV的AUC为0.809,截断值≥3/4肺野时敏感度85.2%、特异度78.6%。
  • APACHE II评分≥16.5预测ETI-MV的AUC为0.704,敏感度83.6%、特异度57.1%,预测价值最低。
  • 多因素分析中院内细菌感染OR=38.338(95%CI 1.638-897.158,P=0.023)、APACHE II评分≥16.5 OR=30.604(95%CI 4.318-216.932,P=0.001)、肺浸润影≥3/4肺野OR=12.527(95%CI 3.279-47.859,P<0.001)为ETI-MV独立危险因素。
  • PaO2/FiO2(OR=0.948,95%CI 0.925-0.972,P<0.001)与CD4+ T淋巴细胞计数(OR=0.975,95%CI 0.955-0.995,P=0.015)为ETI-MV独立保护因素。

适用人群与场景

  • 新疆医科大学第一附属医院呼吸重症监护病房(RICU)2017年11月至2022年3月收治的病毒性肺炎所致ARDS患者,共117例,ETI-MV组61例、非ETI-MV组56例。

诊断标准与关键阈值

  • ARDS严重程度按轻、中、重分组:ETI-MV组轻度3例(4.9%)、中度39例(63.9%)、重度19例(31.1%);非ETI-MV组轻度16例(28.6%)、中度38例(67.8%)、重度2例(3.6%),两组差异有统计学意义(P<0.05)。
  • PaO2/FiO2预测ETI-MV的截断值为151 mmHg(1 mmHg≈0.133 kPa)。
  • APACHE II评分预测ETI-MV的截断值为16.5分。
  • 肺浸润影分布范围预测ETI-MV的截断值为≥3/4肺野。

研究设计与关键结果

  • 研究类型为回顾性分析,单中心(新疆医科大学第一附属医院RICU),纳入117例病毒性肺炎所致ARDS患者,比较ETI-MV组(61例)与非ETI-MV组(56例)。
  • 单因素分析显示,入RICU 24小时内IL-6(ng/L)ETI-MV组104.0±90.0 vs 非ETI-MV组62.4±76.0、PaO2/FiO2(mmHg)ETI-MV组123.9±30.9 vs 非ETI-MV组173.6±28.5、肺浸润影分布范围≥3/4肺野比例ETI-MV组85.3%(52/61)vs 非ETI-MV组21.5%(12/56)、APACHE II评分≥16.5比例ETI-MV组67.2%(41/61)vs 非ETI-MV组42.9%(24/56)、院内侵袭性曲霉菌感染率ETI-MV组14.8%(9/61)vs 非ETI-MV组3.6%(2/56)、院内细菌感染率ETI-MV组16.4%(10/61)vs 非ETI-MV组3.6%(2/56)、病程中CD4+ T淋巴细胞最低计数(cells/mm3)ETI-MV组192.2±35.8 vs 非ETI-MV组2
  • 多因素Logistic回归显示,入RICU 24小时内肺浸润影分布范围≥3/4肺野(OR=12.527,95%CI 3.279-47.859,P<0.001)、APACHE II评分≥16.5(OR=30.604,95%CI 4.318-216.932,P=0.001)、PaO2/FiO2(OR=0.948,95%CI 0.925-0.972,P<0.001)、CD4+ T淋巴细胞计数(OR=0.975,95%CI 0.955-0.995,P=0.015)、院内细菌感染(OR=38.338,95%CI 1.638-897.158,P=0.023)为ETI-MV的独立影响因素。
  • ROC曲线显示,PaO2/FiO2预测ETI-MV的AUC为0.903,截断值151 mmHg时敏感度91.1%、特异度95.1%;肺浸润影分布范围AUC为0.809,截断值≥3/4肺野时敏感度85.2%、特异度78.6%;APACHE II评分AUC为0.704,截断值16.5分时敏感度83.6%、特异度57.1%。

证据类型、等级与局限

  • 证据类型:回顾性分析。

对床旁实践的改变

  • 作者认为,对病毒性肺炎所致ARDS患者,PaO2/FiO2仍是选择ETI-MV的经典参考,而肺浸润影分布范围和入RICU 24小时内全身病情严重程度可为决定是否选择ETI-MV提供补充信息,尤其对中度ARDS。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the influencing factors of endotracheal intubation and mechanical ventilation (ETI-MV) in patients with acute respiratory distress syndrome (ARDS) caused by viral pneumonia, and to provide evidence for individualized use of ETI-MV.

METHODS: Patients with ARDS due to viral pneumonia admitted to the respiratory intensive care unit (RICU) of the First Affiliated Hospital of Xinjiang Medical University were retrospectively analyzed from November 2017 to March 2022. The gender, age, concomitant diseases, clinical symptoms and signs, complications, lab results, ARDS severity, infectious virus type, acute physiology and chronic health evaluation II (APACHE II), respiratory support methods and prognosis-related variables were collected. Univariate analysis was performed on each factor, and the variables with statistical significance in the univariate analysis were subjected multivariate logistic regression analysis. The receiver operating characteristic curve (ROC curve) was drawn to evaluate the predictive value of each index for the implementation of ETI-MV.

RESULTS: A total of 117 patients were enrolled in the study, including 61 patients in the ETI-MV group, and 3 patients (4.9%), 39 patients (63.9%) and 19 patients (31.1%) with mild, moderate and severe ARDS, respectively. There were 56 patients in non-ETI-MV group, and the mild, moderate and severe ARDS cases were 16 cases (28.6%), 38 cases (67.8%) and 2 cases (3.6%), respectively. There was significant difference between the two groups (P < 0.05). Univariate analysis showed that during 24 hours admitted to RICU, the levels of interleukin-6 [IL-6 (ng/L): 104.0±90.0 vs. 62.4±76.0], oxygenation index [PaO2/FiO2 (mmHg, 1 mmHg ≈ 0.133 kPa): 123.9±30.9 vs. 173.6±28.5], the proportion of cases with pulmonary infiltrating opacity distribution range ≥ 3/4 lung fields [85.3% (52/61) vs. 21.5% (12/56)], APACHE II score ≥ 16.5 [67.2% (41/61) vs. 42.9% (24/56)], the rate of nosocomial invasive aspergillus infection [14.8% (9/61) vs. 3.6% (2/56)], the percentage of nosocomial bacterial infection [16.4% (10/61) vs. 3.6% (2/56)], and the lowest CD4+ T lymphocyte count in the course of the disease [cells/mm3: 192.2±35.8 vs. 215.0±58.3] had significant differences between ETI-MV and non-ETI-MV group (all P < 0.05). Multivariate Logistic regression analysis showed that during 24 hours admitted to RICU the distribution range of pulmonary infiltrating opacity ≥ 3/4 the lung fields [odds ratio (OR) = 12.527, 95% confidence interval (95%CI) = 3.279-47.859, P < 0.001], APACHE II score ≥ 16.5 (OR = 30.604, 95%CI = 4.318-216.932, P = 0.001), PaO2/FiO2 (OR = 0.948, 95%CI = 0.925-0.972, P < 0.001), CD4+ T lymphocytes cell count (OR = 0.975, 95%CI = 0.955-0.995, P = 0.015), and nosocomial bacterial infection (OR = 38.338, 95%CI = 1.638-897.158, P = 0.023) were independent risk factors for ETI-MV. The area under the ROC curve (AUC) of ROC showed that PaO2/FiO2 had the greatest predictive value for ETI-MV, with AUC of 0.903, sensitivity of 91.1% and specificity of 95.1% in case of cutoff value of 151 mmHg. The AUC of pulmonary infiltrating opacity distribution range was 0.809, the sensitivity of 85.2%, specificity of 78.6% when the cutoff value was ≥ 3/4 lung field. APACHE II scores had the lowest predictive value for selecting ETI-MV, with AUC of 0.704, sensitivity of 83.6% and specificity of 57.1% under the cutoff value was 16.5.

CONCLUSIONS: For patients with ARDS caused by viral pneumonia, PaO2/FiO2 is still the classic reference for selecting ETI-MV, however, the distribution range of pulmonary infiltrating opacity and the systemic severity of the disease during 24 hours admitted to the RICU may provide supplemental helpful information to determine whether the patients choose ETI-MV, especially for moderate ARDS.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Kang M, Li J, Wan Q, et al. [Factors influencing the choice of endotracheal intubation and mechanical ventilation in patients with acute respiratory distress syndrome caused by viral pneumonia]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35924512. doi:10.3760/cma.j.cn121430-20220607-00549

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。